Evaluating the Efficacy of Mepitel in Post-mastectomy Breast Cancer Patients, and Examining the Role of the Skin Microbiome in Radiation Dermatitis
Evaluating the Efficacy of Mepitel in Post-mastectomy Breast Cancer Patients, and Examining the Role of the Skin Microbiome in Radiation Dermatitis
The aim of this study is to examine alterations in the skin microbiome that occur during radiation therapy. The study design will examine changes secondary to ionizing radiation, and correlate these changes with the development and severity of radiation dermatitis. The goal is to improve understanding of the mechanism of radiation dermatitis.
Inclusion Criteria:
Exclusion Criteria:
Documented history of adhesive or tape allergy
Unable to provide written consent
Patients with prior radiotherapy to any portion of the planned treatment site
Brachytherapy patients
Patients with active rash, pre-existing dermatitis, lupus, or scleroderma
Gross dermal involvement at initiation of radiotherapy
Recent use of systemic or topical antibiotics or antifungal medications within 14 days of swab collection
Recent use of any of the following within 14 days of swab collection:
Clinical evidence of infection that in the judgement of the principle investigator would interfere with proper assessment of the skin microbiome
Prior organ or bone marrow transplant
Current lactation
Undergoing bilateral radiation